Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06884098 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 20, 2025 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
Addpharma Inc.
28 trials monitored
See 1 trial at risk
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228B in healthy subjects.
Trial Details
NCT Number NCT06884098
Lead Sponsor Addpharma Inc.
Conditions
(from sponsor)		 Primary Hypercholesterolaemia
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov